Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report

A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.

Detalles Bibliográficos
Autores principales: Lansang, Rafael Paolo, Zhao, Irene X, Lansang, Perla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
JCMS Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291146/
https://www.ncbi.nlm.nih.gov/pubmed/37377458
http://dx.doi.org/10.1177/2050313X231180766
_version_ 1785062636571852800
author Lansang, Rafael Paolo
Zhao, Irene X
Lansang, Perla
author_facet Lansang, Rafael Paolo
Zhao, Irene X
Lansang, Perla
author_sort Lansang, Rafael Paolo
collection PubMed
description A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.
format Online
Article
Text
id pubmed-10291146
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-102911462023-06-27 Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report Lansang, Rafael Paolo Zhao, Irene X Lansang, Perla SAGE Open Med Case Rep JCMS Case Report A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months. SAGE Publications 2023-06-14 /pmc/articles/PMC10291146/ /pubmed/37377458 http://dx.doi.org/10.1177/2050313X231180766 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle JCMS Case Report
Lansang, Rafael Paolo
Zhao, Irene X
Lansang, Perla
Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_full Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_fullStr Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_full_unstemmed Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_short Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report
title_sort atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: a case report
topic JCMS Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291146/
https://www.ncbi.nlm.nih.gov/pubmed/37377458
http://dx.doi.org/10.1177/2050313X231180766
work_keys_str_mv AT lansangrafaelpaolo atopicdermatitistreatedwithtralokinumabandupadacitinibcombinationtherapyacasereport
AT zhaoirenex atopicdermatitistreatedwithtralokinumabandupadacitinibcombinationtherapyacasereport
AT lansangperla atopicdermatitistreatedwithtralokinumabandupadacitinibcombinationtherapyacasereport

Ejemplares similares